RBI
NVS icon

Raiffeisen Bank International’s Novartis NVS Stock Holding History

Raiffeisen Bank International’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.8K Hold
255
– – ﹤0.01% 611
2026
Q1 		$38K Hold
255
– – ﹤0.01% 589
2025
Q4 		$26.9K Hold
255
– – ﹤0.01% 599
2025
Q3 		$32.6K Buy
+255
New +$31.1K ﹤0.01% 580

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $10B AUM 30.45% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AM
AGF Management Toronto, Ontario, Canada $25.8B AUM 56.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Raiffeisen Bank International's NVS Position: Q3 2025 in Review

Raiffeisen Bank International sold out of Novartis (NVS) in Q3 2025, closing a stake of 255 shares — an estimated $31.1K sold.

Raiffeisen Bank International first reported a position in NVS in Q4 2024 and held it in 3 quarters. The position peaked at $30K in Q2 2025. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Raiffeisen Bank International reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Raiffeisen Bank International sold 255 Novartis shares in Q3 2025, an estimated $31.1K.
  • Raiffeisen Bank International first reported a position in Novartis in Q4 2024 and held it in 3 quarters.
  • Raiffeisen Bank International's Novartis position peaked at $30K in Q2 2025.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Raiffeisen Bank International's 13F filing for Q3 2025, filed 10 Nov 2025.